NDT Advance Access published online on November 25, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfi273
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Division of Hypertension and Nephrology, Kyoto Prefectural University of Medicine, Kyoto
* To whom correspondence should be addressed. Background. Marked parathyroid hyperplasia with bone diseases and vascular calcification are unsolved issues in dialysis patients. In this study, we made azotemic model rats by adenine feeding and analyzed the development and progression of the abnormalities. Methods. Renal failure was induced in 8-week-old male Wistar rats by feeding 0.75% adenine-containing diet for 6 weeks. Serum parameters, parathyroid hyperplasia, bone changes and metastatic calcification were examined at 2, 4 and 6 weeks. Results. Progressive increase of serum creatinine and inorganic phosphate, and decreased levels of serum calcium and 1,25(OH)2D3 were confirmed. Markedly enlarged parathyroid glands and extremely high PTH levels were observed in all adenine-fed rats compared with the control (PTH: 199.3±58.0 vs 10.5±3.0 pmol/l, P<0.01, respectively, at 6 weeks). In cortical bone of the femur, the morphometric parameters showed increased bone resorption with increased fibrosis, whereas in the trabecular bone, bone resorption decreased and bone volume increased with a larger amount of osteoid compared with the control. Metastatic calcification in aorta, coronary artery and other soft tissues were also found in adenine-fed rats. Conclusions. Uraemic rats made by adenine diet developed severe abnormalities of calcium metabolism in a relatively short period and therefore they may serve as a useful model for the analysis of parathyroid hyperplasia and vascular calcification in chronic renal failure.
Received August 31, 2004
Accepted October 24, 2005
Original Article
Severe hyperparathyroidism with bone abnormalities and metastatic calcification in uraemic rats fed on adenine diet
Keiichi Tamagaki 1,
Qunsheng Yuan 2,
Hiroyuki Ohkawa
3,
Ikuo Imazeki 3,
Yoshiyuki Moriguchi 3,
Nobuo Imai 3,
Susumu Sasaki 1,
Kazuo Takeda 1,
and
Masafumi Fukagawa 2 *
2 Division of Nephrology and Dialysis Center, Kobe University School of Medicine, Kobe
3 Product Research Lab, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan
Masafumi Fukagawa, E-mail: fukagawa{at}med.kobe-u.ac.jp
Abstract Deceased
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. G. Graciolli, K. R. Neves, L. M. dos Reis, R. G. Graciolli, I. L. Noronha, R. M. A. Moyses, and V. Jorgetti Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1416 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mathew, K. S. Tustison, T. Sugatani, L. R. Chaudhary, L. Rifas, and K. A. Hruska The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKD J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1092 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Drueke, D. Martin, and M. Rodriguez Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1828 - 1839. [Full Text] [PDF]
|
|